Emphycorp News and Peer Reviewed Articles
Emphycorp News and Peer Reviewed Articles
Non-Steroidal Nasal Sprays with no adverse effects for Treatment of Respiratory Diseases, COVID-19, Long COVID, Flu, and more.
Emphycorp News and Peer Reviewed Articles
To read and or download the pdf articles click on the links below.
JAMAPDD Published Peer Review “Sodium Pyruvate Nasal Spray Reduces the Severity of Nasal Inflammation and Congestion in Patients with Allergic Rhinitis Sept 2022.
- EJRM Peer Review – Inhaled Sodium Pyruvate Reduces Oxygen Radicals and Inflammatory Cytokines in COPD Patients 073022
- EJRM Peer Review – Inhalation of Sodium Pyruvate to Reduce Hypoxemia and Dyspnea Associated with Chronic Respiratory Diseases- A Multi-Study Retrospective Analysis 011922
- Inhalation of Sodium Pyruvate to Reduce the Symptoms and Severity of Respiratory Diseases Including COVID-19, Long COVID, and Pulmonary Fibrosis.
- October 11, 2021 – N115 Nasal Spray Found to Improve Lung Function in PF Patients
- July 2020 – Inhaled Nebulized Sodium Pyruvate for COVID-19 – Israel Medical Association Journal
- May 2020 – Pyruvate affects inflammatory responses of macrophages during influenza A virus infection – Elsevier Virus Research EmphyCorp p 7-8 highlighted
